Novartis and its Alcon Division Report Marginally Increased Global Sales in 2014

Novartis sales increased 1%, or 3% at constant exchange rates to $ US 58 billion ($74 billion CDN). The company expects growth of approximately 5% of its net sales in 2015. Alcon, a Novartis division since 2010, reported an increase of 3% in 2014 to US $10.8 billion ($13.7 billion CDN). Sales of the Vision Care segment, which includes the launch of Dailies Total1 lenses and AirOptix Colors, increased by 2%, while sales of contact lens care products declined.

The surgery business increased by 5%, while Ophthalmic Pharmaceuticals grew by 3% due to good performance of Systane of Ilevro and treatments for glaucoma.

The Novartis report did not provide any North American or Canadian results relating to the Alcon Division.

For more information:

http://www.novartis.com/downloads/investors/financial-results/quarterly-results/q4-2014-media-release_en.pdf

Featured Posts

MIDO 2023: Visitor Registration Now Open

Starting now, show goers can reserve their spot at the 2023 edition of MIDO

Learn More

FYidoctors Named Among Canada’s Top Growing Companies in Latest Report on Business Ranking

Diversified healthcare organization has grown to include 375 clinics across Canada

Read more

Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress

One Podium and Two Poster Presentations Will Highlight Pre-Clinical and Clinical Data for Investigational Treatment NOV03, as well as Data from Company’s Unique ARMOR Surveillance Study

Read more

Transitions and OAC Now Accepting Applications for the 2022 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eye care

Read more

Travel Yukon and Enchroma Help People With Colourblindness See the Northern Lights

Travel Yukon and EnChroma came together to make the show-stopping northern lights more accessible than ever before for the colourblind, and provided one Canadian with the chance to see this natural phenomenon in full colour for the first time.

Read more

MIDO 2023: Visitor Registration Now Open

Starting now, show goers can reserve their spot at the 2023 edition of MIDO

Learn More

FYidoctors Named Among Canada’s Top Growing Companies in Latest Report on Business Ranking

Diversified healthcare organization has grown to include 375 clinics across Canada

Read More

Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress

One Podium and Two Poster Presentations Will Highlight Pre-Clinical and Clinical Data for Investigational Treatment NOV03, as well as Data from Company’s Unique ARMOR Surveillance Study

Read More

Transitions and OAC Now Accepting Applications for the 2022 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eye care

Read More

Travel Yukon and Enchroma Help People With Colourblindness See the Northern Lights

Travel Yukon and EnChroma came together to make the show-stopping northern lights more accessible than ever before for the colourblind, and provided one Canadian with the chance to see this natural phenomenon in full colour for the first time.

Read More

MIDO 2023: Visitor Registration Now Open

Starting now, show goers can reserve their spot at the 2023 edition of MIDO

Learn More

FYidoctors Named Among Canada’s Top Growing Companies in Latest Report on Business Ranking

Diversified healthcare organization has grown to include 375 clinics across Canada

Read more

Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress

One Podium and Two Poster Presentations Will Highlight Pre-Clinical and Clinical Data for Investigational Treatment NOV03, as well as Data from Company’s Unique ARMOR Surveillance Study

Read more

Transitions and OAC Now Accepting Applications for the 2022 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eye care

Read more

Travel Yukon and Enchroma Help People With Colourblindness See the Northern Lights

Travel Yukon and EnChroma came together to make the show-stopping northern lights more accessible than ever before for the colourblind, and provided one Canadian with the chance to see this natural phenomenon in full colour for the first time.

Read more

MIDO 2023: Visitor Registration Now Open

Starting now, show goers can reserve their spot at the 2023 edition of MIDO

Learn More

FYidoctors Named Among Canada’s Top Growing Companies in Latest Report on Business Ranking

Diversified healthcare organization has grown to include 375 clinics across Canada

Read more

Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress

One Podium and Two Poster Presentations Will Highlight Pre-Clinical and Clinical Data for Investigational Treatment NOV03, as well as Data from Company’s Unique ARMOR Surveillance Study

Read more

Transitions and OAC Now Accepting Applications for the 2022 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eye care

Read more

Travel Yukon and Enchroma Help People With Colourblindness See the Northern Lights

Travel Yukon and EnChroma came together to make the show-stopping northern lights more accessible than ever before for the colourblind, and provided one Canadian with the chance to see this natural phenomenon in full colour for the first time.

Read more